These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30191805)

  • 41. Emergence of Global Antibiotic Resistance.
    Morehead MS; Scarbrough C
    Prim Care; 2018 Sep; 45(3):467-484. PubMed ID: 30115335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria.
    Moravej H; Moravej Z; Yazdanparast M; Heiat M; Mirhosseini A; Moosazadeh Moghaddam M; Mirnejad R
    Microb Drug Resist; 2018; 24(6):747-767. PubMed ID: 29957118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defining and combating antibiotic resistance from One Health and Global Health perspectives.
    Hernando-Amado S; Coque TM; Baquero F; Martínez JL
    Nat Microbiol; 2019 Sep; 4(9):1432-1442. PubMed ID: 31439928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The food safety perspective of antibiotic resistance.
    McDermott PF; Zhao S; Wagner DD; Simjee S; Walker RD; White DG
    Anim Biotechnol; 2002 May; 13(1):71-84. PubMed ID: 12212946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the future.
    Giske CG; Cornaglia G;
    Drug Resist Updat; 2010; 13(4-5):93-8. PubMed ID: 20864384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. European recommendations for antimicrobial resistance surveillance.
    Cornaglia G; Hryniewicz W; Jarlier V; Kahlmeter G; Mittermayer H; Stratchounski L; Baquero F;
    Clin Microbiol Infect; 2004 Apr; 10(4):349-83. PubMed ID: 15059129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years.
    Ironmonger D; Edeghere O; Bains A; Loy R; Woodford N; Hawkey PM
    J Antimicrob Chemother; 2015; 70(6):1744-50. PubMed ID: 25733586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The resistance tsunami, antimicrobial stewardship, and the golden age of microbiology.
    Prescott JF
    Vet Microbiol; 2014 Jul; 171(3-4):273-8. PubMed ID: 24646601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme.
    Karlowsky JA; Biedenbach DJ; Bouchillon SK; Iaconis JP; Reiszner E; Sahm DF
    J Antimicrob Chemother; 2016 Jan; 71(1):162-9. PubMed ID: 26503667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neonatal bloodstream infections in a Ghanaian Tertiary Hospital: Are the current antibiotic recommendations adequate?
    Labi AK; Obeng-Nkrumah N; Bjerrum S; Enweronu-Laryea C; Newman MJ
    BMC Infect Dis; 2016 Oct; 16(1):598. PubMed ID: 27776490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial resistance: a global multifaceted phenomenon.
    Prestinaci F; Pezzotti P; Pantosti A
    Pathog Glob Health; 2015; 109(7):309-18. PubMed ID: 26343252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of whole genome sequencing in monitoring antimicrobial resistance: A biosafety and public health priority in the Arabian Peninsula.
    Alghoribi MF; Balkhy HH; Woodford N; Ellington MJ
    J Infect Public Health; 2018; 11(6):784-787. PubMed ID: 30100241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infectious drug resistance.
    Lewis BA
    J Natl Med Assoc; 1985 Feb; 77(2):139-41. PubMed ID: 3981648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tackling the threat of antimicrobial resistance: from policy to sustainable action.
    Shallcross LJ; Howard SJ; Fowler T; Davies SC
    Philos Trans R Soc Lond B Biol Sci; 2015 Jun; 370(1670):20140082. PubMed ID: 25918440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Control of antibiotic-resistant bacteria: memorandum from a WHO meeting.
    Bull World Health Organ; 1983; 61(3):423-33. PubMed ID: 6603916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotic usage in animals: impact on bacterial resistance and public health.
    van den Bogaard AE; Stobberingh EE
    Drugs; 1999 Oct; 58(4):589-607. PubMed ID: 10551432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations.
    Abat C; Rolain JM; Dubourg G; Fournier PE; Chaudet H; Raoult D
    Clin Infect Dis; 2017 Aug; 65(suppl_1):S58-S63. PubMed ID: 28859341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of global surveillance in combating bacterial resistance.
    Marchese A; Schito GC
    Drugs; 2001; 61(2):167-73. PubMed ID: 11270935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decrease in antibiotic susceptibility or increase in resistance?--defects of present antimicrobial susceptibility surveillance.
    MacGowan A; Bennett P
    J Antimicrob Chemother; 1998 Oct; 42(4):547-8. PubMed ID: 9818759
    [No Abstract]   [Full Text] [Related]  

  • 60. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R; Noriega ER; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.